Skip to content

Clinical trials

Phase 1 Epilepsy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 1 Country / region: United States Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20053
20062
20073
20085
20102
20115
20123
20132
20144
20154
20161
20172
20193
20202
20214
20223
20245
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Recruiting7
Terminated6
Not yet recruiting4
Active, not recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
National Institute of Neurological Disorders and Stroke (NINDS)5
Eli Lilly and Company3
Mayo Clinic3
NeuroPro Therapeutics, Inc.3
University of Minnesota3
University of Texas Southwestern Medical Center3
Bial - Portela C S.A.2
Johns Hopkins University2
NYU Langone Health2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy66
Seizures14
Drug Resistant Epilepsy5
Memory Disorders3
Alzheimer Disease2
Central Nervous System Diseases2
Cognitive Dysfunction2
Neurocysticercosis2
Neuroinflammatory Diseases2
Taeniasis2

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.